SEC Filing Summary: India Globalization Capital, Inc.
Business Context and Reporting Period
This Form 8-K was filed by India Globalization Capital, Inc. (not IGC Pharma, Inc.) on November 27, 2006. The report covers events occurring on that date regarding changes in the company's principal officers and board composition.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
- Departure of Principal Officers: On November 27, 2006, John Cherin resigned from his positions as a member of the Board of Directors, Chief Financial Officer, and Treasurer.
- Reason for Departure: Mr. Cherin resigned to devote more time to personal matters.
Guidance, Outlook, and Risks
The filing does not contain management commentary on future guidance, outlook, or specific risks beyond the immediate impact of the executive departure. A press release dated December 1, 2006, is attached as Exhibit 99.1 but its content is not detailed in the filing text provided.
Key Facts for Investor Verification
- Verify the appointment of a new Chief Financial Officer and Treasurer to replace John Cherin.
- Confirm the status of the Board of Directors following Mr. Cherin's resignation.
- Review the attached press release (Exhibit 99.1) for additional context on the transition.
- Note the discrepancy between the requested company name (IGC Pharma, Inc.) and the actual registrant (India Globalization Capital, Inc.).